蜕膜化
转录组
生物
甲基化
蜕膜
表观遗传学
小桶
DNA甲基化
基因
RNA序列
差异甲基化区
间质细胞
基因表达
遗传学
胎盘
癌症研究
怀孕
胎儿
作者
Yong Luo,Jin Chen,Ying Cui,Fang Fang,Ziyu Zhang,Lili Hu,Xiaoyong Chen,Zengming Li,Liping Li,Lina Chen
标识
DOI:10.1096/fj.202201232rrrr
摘要
Abstract Recurrent spontaneous abortion (RSA) is characterized by two or more consecutive pregnancy losses in the first trimester of pregnancy, experienced by 5% of women during their reproductive age. As a complex pathological process, the etiology of RSA remains poorly understood. Recent studies have established that gene expression changes dramatically in human endometrial stromal cells (ESCs) during decidualization. N6‐methyladenosine (m 6 A) modification is the most prevalent epigenetic modification of mRNA in eukaryotic cells and it is closely related to the occurrence and development of many pathophysiological phenomena. In this study, we first confirmed that high levels of m 6 A mRNA methylation in decidual tissues are associated with RSA. Then, we used m 6 A‐modified RNA immunoprecipitation sequence (m 6 A‐seq) and RNA sequence (RNA‐seq) to identify the differentially expressed m 6 A methylation in decidual tissues from RSA patients and identified the key genes involved in abnormal decidualization by bioinformatics analysis. Using m 6 A‐seq, we identified a total of 2169 genes with differentially expressed m 6 A methylation, of which 735 m 6 A hypermethylated genes and 1434 m 6 A hypomethylated genes were identified. Further joint analysis of m 6 A‐seq and RNA‐seq revealed that 133 genes were m 6 A modified with mRNA expression. GO and KEGG analyses indicated that these unique genes were mainly enriched in environmental information processing pathways, including the cytokine–cytokine receptor interaction and PI3K‐Akt signaling pathway. In summary, this study uncovered the transcriptome‐wide m 6 A modification pattern in decidual tissue of RSA, which provides a theoretical basis for further research into m 6 A modification and new therapeutic strategies for RSA.
科研通智能强力驱动
Strongly Powered by AbleSci AI